Yüklüyor......
Right ventricular size and function under riociguat in pulmonary arterial hypertension and chronic thromboembolic pulmonary hypertension (the RIVER study)
BACKGROUND: Riociguat is a soluble guanylate cyclase stimulator approved for pulmonary arterial hypertension (PAH) and chronic thromboembolic pulmonary hypertension (CTPEH). The objective of this study was to evaluate right heart size and function assessed by echocardiography during long term treatm...
Kaydedildi:
| Yayımlandı: | Respir Res |
|---|---|
| Asıl Yazarlar: | , , , , , , , , , , , , , , , |
| Materyal Türü: | Artigo |
| Dil: | Inglês |
| Baskı/Yayın Bilgisi: |
BioMed Central
2018
|
| Konular: | |
| Online Erişim: | https://ncbi.nlm.nih.gov/pmc/articles/PMC6299931/ https://ncbi.nlm.nih.gov/pubmed/30567595 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s12931-018-0957-y |
| Etiketler: |
Etiketle
Etiket eklenmemiş, İlk siz ekleyin!
|